This decision follows the hearing of the president of Merck in France in Marseille on Tuesday, explains the group.
Le Monde
New judicial chapter. It is by voice of a press release that the French subsidiary of the German pharmaceutical laboratory Merck announced, Wednesday, October 19, its indictment for “aggravated deception” in the case of the change of formula of the drug levothyrox.
“The president of Merck in France was heard” in Marseille on Tuesday, explains the group, adding that it was following this hearing that the investigating judge decided to indicate.
/Media reports.